CLINICAL_TRIALS
trial_result
· 2009-12-15
Clinical Trial Update: A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g [Phase 2]
Summary
Phase 2 study evaluating Xolair (omalizumab) in peanut-allergic subjects; the trial has completed and results were posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: Peanut Hypersensitivity | Phase 2 | Status: COMPLETED | Results posted: 2009-12-15